![Russ B. Altman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Russ B. Altman is the founder of Personalis, Inc. founded in 2011.
He currently serves as an Advisory Board member at Digitaldx Ventures Management LLC.
Previously, he worked as a Director at Youscript, Inc.
| Bedrijven | Functie | Begin |
|---|---|---|
Digitaldx Ventures Management LLC
 Digitaldx Ventures Management LLC Investment ManagersFinance Digitaldx Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of artificial intelligence and healthcare sectors. It provides financing for early stage capital requirements. | Consultant / Adviseur | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Youscript, Inc.
 Youscript, Inc. Packaged SoftwareTechnology Services Provides pharmacogenomics research, insights and software solutions that help make precision prescribing possible | Directeur/Bestuurslid | - |
| PERSONALIS, INC. | Oprichter | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 3 |
|---|---|
Personalis, Inc.
 Personalis, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer genomics company which transforms the development of next-generation therapies | Health Services |
Digitaldx Ventures Management LLC
Digitaldx Ventures Management LLC Investment ManagersFinance Digitaldx Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of artificial intelligence and healthcare sectors. It provides financing for early stage capital requirements. | Finance |
Youscript, Inc.
Youscript, Inc. Packaged SoftwareTechnology Services Provides pharmacogenomics research, insights and software solutions that help make precision prescribing possible | Technology Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau
Kies MarketScreener 
